Primary aldosteronism: From genesis to genetics

Trends in Endocrinology and Metabolism

Volumn 14, Issue 7, 2003, Pages 310-317

  Stowasser, Michael ^a   Gordon, Richard D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; CYTOCHROME P450; HYBRID PROTEIN; KALLIKREIN; POTASSIUM; SODIUM; STEROID 11BETA MONOOXYGENASE; UNCLASSIFIED DRUG;

ALDOSTERONE BLOOD LEVEL; CARDIOVASCULAR SYSTEM; CLINICAL FEATURE; GENETIC DISORDER; GENETIC PREDISPOSITION; HUMAN; HYPERTENSION; HYPOKALEMIA; LABORATORY DIAGNOSIS; PATHOGENESIS; PEDIGREE; PHENOTYPE; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REVIEW; SODIUM EXCRETION;

EID: 0042335982     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(03)00112-7     Document Type: Review

References (70)

1. Gordon, R.D. et al. (1994) Primary aldosteronism and other forms of mineralocorticoid hypertension. In Textbook of Hypertension (Swales, J.D., ed.), pp. 865-892, Blackwell
2. Young, W.F. Jr (1999) Primary aldosteronism: a common and curable form of hypertension. Cardiol. Rev. 7, 207-214
3. Lim, P.O. et al. (2000) High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J. Hum. Hypertens. 14, 311-315
4. Loh, K-C. et al. (2000) Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J. Clin. Endocrinol. Metab. 85, 2854-2859
5. Rayner, B.L. et al. (2000) The aldosterone/renin ratio as a screening test for primary aldosteronism. S. Afr. Med. J. 90, 394-400
6. Fardella, C.E. et al. (2000) Primary aldosteronism in essential hypertensives: prevalence, biochemical profile and molecular biology. J. Clin. Endocrinol. Metab. 85, 1863-1867
7. Lifton, R.P. et al. (1992) A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355, 262-265
8. Gordon, R.D. and Stowasser, M. (1998) Familial forms broaden horizons in primary aldosteronism. Trends Endocrinol. Metab. 9, 220-227
9. Stowasser, M. and Gordon, R.D. (2001) Familial hyperaldosteronism. J. Steroid Biochem. Mol. Biol. 78, 215-229
10. Stowasser, M. et al. (2001) Diagnosis and management of primary aldosteronism. J. Renin Angiotensin Aldosterone Syst. 2, 156-169
11. Conn, J.W. (1966) The evolution of primary aldosteronism: 1954-1967. Harvey Lect. 62, 257-291
12. Hiramatsu, K. et al. (1981) A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Arch. Intern. Med. 141, 1589-1593
13. Gordon, R.D. et al. (1992) Primary aldosteronism: hypertension with a genetic basis. Lancet 340, 159-161
14. Gordon, R.D. (2001) Diagnostic investigations in primary aldosteronism. In Clinical Medicine Series on Hypertension (Zanchetti, A., ed.), pp. 101-114, McGraw-Hill International
15. Gordon, R.D. et al. (1994) High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin. Exp. Pharmacol. Physiol. 21, 315-318
16. Brown, M.A. et al. (1996) Primary aldosteronism: a missed diagnosis in 'essential hypertensives'? Aust. N. Z. J. Med. 26, 533-538
17. Nishikawa, T. and Omura, M. (2000) Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. Biomed. Pharmacother. 54 (Suppl. 1), 83s-85s
18. Gallay, B.J. et al. (2001) Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am. J. Kidney Dis. 37, 699-705
19. Schwartz, G.L. and Turner, S.T. (2002) Predictive value of the aldosterone-renin ratio in screening for primary aldosteronism. Am. J. Hypertens. 15, 226A
20. Hood, S. et al. (2002) Prevalence of primary hyperaldosteronism measured by aldosterone to renin ratio and spironolactone testing: PHARST study. J. Hypertens. 20 (Suppl. 4), S119
21. Calhoun, D.A. et al. (2002) High prevalence of primary aldosteronism among black and white subjects with resistant hypertension. J. Hypertens. 20 (Suppl. 4), S122
22. Weber, K.T. and Brilla, C.G. (1991) Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 83, 1849-1865
23. Rossi, G.P. et al. (1997) Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 95, 1471-1478
24. Pitt, B. et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N. Engl. J. Med. 341, 709-717
25. Gordon, R.D. (1995) Primary aldosteronism. J. Endocrinol. Invest. 18, 495-511
26. Streeten, D.H. et al. (1990) Effect of age on response of secondary hypertension to specific treatment. Am. J. Hypertens. 3, 360-365
27. Stowasser, M. et al. (1994) Response to unilateral adrenalectomy for aldosterone-producing adenoma - effect of angiotensin responsiveness and potassium levels. Clin. Exp. Pharmacol. Physiol. 21, 319-322
28. Celen, O. et al. (1996) Factors influencing outcome of surgery for primary aldosteronism. Arch. Surg. 131, 646-650
29. Gordon, R.D. et al. (1987) Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension. J. Hypertens. Suppl. 5, S103-S106
30. Kaplan, N.M. (2001) Cautions over the current epidemic of primary aldosteronism. Lancet 357, 953-954
31. Padfield, P.L. (2002) Primary aldosteronism, a common entity? The myth persists. J. Hum. Hypertens. 16, 159-162
32. Gordon, R.D. et al. (2001) Primary aldosteronism: are we diagnosing and operating on too few patients? World J. Surg. 25, 941-947
33. Nishikawa, T. et al. (2002) Prevalence of primary aldosteronism among Japanese hypertensive patients. J. Hypertens. 20 (Suppl. 4), S172
34. Rossi, G.P. et al. (2001) Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J. Clin. Endocrinol. Metab. 86, 1083-1090
35. McAlister, F.A. and Lewanczuk, R.Z. (1998) Primary hyperaldosteronism and adrenal incidentaloma: an argument for physiological testing before adrenalectomy. Can. J. Surg. 41, 299-305
36. Rutherford, J.C. et al. (1998) Success of surgery in primary aldosteronism judged by residual autonomous aldosterone production. World J. Surg. 22, 1243-1245
37. Rossi, G.P. et al. (1996) Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 27, 1039-1045
38. Sutherland, D.J.A. et al. (1966) Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can. Med. Assoc. J. 95, 1109-1119
39. Pascoe, L. et al. (1995) Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. J. Clin. Invest. 96, 2236-2246
40. Ulick, S. and Chu, M.D. (1982) Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension. Clin. Exp. Hypertens. A4, 1771-1777
41. Findling, J.W. et al. (1997) Liddle's syndrome: prospective genetic screening and suppressed aldosterone secretion in an extended kindred. J. Clin. Endocrinol. Metab. 82, 1071-1074
42. Wilson, R.C. et al. (1998) A genetic defect resulting in mild low-renin hypertension. Proc. Natl. Acad. Sci. U. S. A. 95, 10200-10205
43. Geller, D.S. et al. (2000) Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289, 119-123
44. Stowasser, M. et al. (2000) Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and to degree of biochemical disturbance. J. Clin. Endocrinol. Metab. 85, 2160-2166
45. Stowasser, M. et al. (1999) Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I. J. Clin. Endocrinol. Metab. 84, 4031-4036
46. Mulatero, P. et al. (2002) Glucocorticoid-remediable aldosteronism: low morbidity and mortality in a four-generation Italian pedigree. J. Clin. Endocrinol. Metab. 87, 3187-3191
47. Jamieson, A. et al. (1995) Glucocorticoid-suppressible hyperaldosteronism: effects of crossover site and parental origin of chimaeric gene on phenotypic expression. Clin. Sci. 88, 563-570
48. Stowasser, M. et al. (1993) Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis. J. Clin. Endocrinol. Metab. 77, 800-804
49. Dluhy, R.G. and Lifton, R.P. (1995) Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis. Steroids 60, 48-51
50. Mulatero, P. et al. (2002) Blood pressure in patients with primary aldosteronism is influenced by bradykinin B2 receptor and α-adducin gene polymorphisms. J. Clin. Endocrinol. Metab. 87, 3337-3343
51. Stowasser, M. et al. (1997) In familial hyperaldosteronism type I, hybrid gene-induced aldosterone production dominates that induced by wild type genes. J. Clin. Endocrinol. Metab. 82, 3670-3676
52. Ganguly, A. (1998) Primary aldosteronism. N. Engl. J. Med. 339, 1828-1834
53. Stowasser, M. et al. (2000) Treatment of familial hyperaldosteronism type I: only partial suppression of hybrid gene required to correct hypertension. J. Clin. Endocrinol. Metab. 85, 3313-3318
54. Stowasser, M. and Gordon, R.D. (2000) Primary aldosteronism: learning from the study of familial varieties. J. Hypertens. 18, 1165-1176
55. Gordon, R.D. et al. (1991) Clinical and pathological diversity of primary aldosteronism including a new familial variety. Clin. Exp. Pharmacol. Physiol. 18, 283-286
56. London, N. et al. (1992) Familial Conn's syndrome. Postgrad. Med. J. 68, 976-977
57. Nakatani, M. et al. (1992) Lineage of familial aldosterone-producing adenoma (Abstract). Proc. Ninth Intl. Congress Endocrin. P-04.31.027
58. Fallo, F. et al. (2000) Genetic studies in familial aldosteronism not suppressible by dexamethasone. J. Endocrinol. Genet. 1, 159-164
59. Iida, A. et al. (1995) Allelic losses on chromosome 11q13 in aldosterone-producing adrenal tumors. Genes Chromosomes Cancer 12, 73-75
60. Gordon, R.D. et al. (1996) Different allelic patterns at chromosome 11q13 in paired aldosterone-producing tumours and blood DNA. Clin. Exp. Pharmacol. Physiol. 23, 594-596
61. Klemm, S.A. et al. (1995) PCR-SSCP analysis of the angiotensin II type 1 receptor gene in patients with aldosterone-producing adenomas. Clin. Exp. Pharmacol. Physiol. 22, 457-459
62. Ballantine, D.M. et al. (1996) PCR-SSCP analysis of the p53 gene in tumours of the adrenal gland. Clin. Exp. Pharmacol. Physiol. 23, 582-583
63. Hampf, M. et al. (1998) Aldosterone synthase gene in patients suffering from hyperaldosteronism. Endocr. Res. 24, 877-880
64. Lim, P.O. et al. (2002) Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio. J. Clin. Endocrinol. Metab. 87, 4398-4402
65. Torpy, D.J. et al. (1998) Familial hyperaldosteronism type-II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene. J. Clin. Endocrinol. Metab. 83, 3214-3218
66. Torpy, D.J. et al. (1998) Linkage analysis of familial hyperaldosteronism type II - absence of linkage of the gene encoding the angiotensin II receptor type 1. J. Clin. Endocrinol. Metab. 83, 1046
67. Lafferty, A.R. et al. (2000) A novel locus for low-renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J. Med. Genet. 37, 831-835
68. McKnight, G.S. et al. (1988) Analysis of the cAMP-dependent protein kinase system using molecular genetic approaches. Recent Prog. Horm. Res. 44, 307-335
69. Kirschner, L.S. et al. (2000) Mutations of the gene encoding the protein kinase A type 1-α regulatory subunit in patients with the Carney complex. Nat. Genet. 26, 89-92
70. Stowasser, M. et al. (1997) A PCR-based method of screening individuals of all ages, from neonates to the elderly, for familial hyperaldosteronism type I. Aust. N. Z. J. Med. 27, 685-690